A new AI-assisted brain atlas that can help visualize the human brain in unprecedented detail has been developed by UCL researchers, in a major step forward for neuroscience and neuroimaging.

Investing in pharmaceutical companies with diversified revenue bases and strong R&D pipelines could be a lucrative strategy.

A new study shows that oxidative stress—an imbalance between damaging molecules and antioxidants—may contribute to repetitive behaviors observed in mice, similar to those seen in autism spectrum ...

The brain does not need its sophisticated cortex to interpret the visual world. A new study published in PLOS Biology ...

Caricature artists exaggerate distinctive features of an individual, deepening a cleft chin or multiplying freckles. Yale ...

A new AI-powered atlas called NextBrain allows researchers to visualize the human brain in unprecedented detail, down to hundreds of tiny subregions previously invisible on MRI scans.

Precision Neuroscience’s brain-computer interface—a wireless device that aims to restore function to people with paralysis—is ...

In the evolving domain of European defense and security affairs policy, cognitive neuroscience and artificial intelligence have emerged as influential ...

The pharma company's newer immunology drugs, Skyrizi and Rinvoq, have delivered robust sales growth that's proving to be the ...

Sobriety didn’t restore the old version of me; it allowed me to build a new one from the driftwood of the past,” ...

Now, a new neuroscientific study from MIT suggests a fascinating explanation. In short, when your attention vanishes after a ...

Walking 3,000 to 7,500 steps daily may slow cognitive decline in older adults with early Alzheimer's, reducing tau buildup ...